Skip to main content

Advertisement

Table 1 Studies published in peer-reviewed journals on the antithrombotic treatment of patients on OAC undergoing PCI-S

From: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis

Author Design of the study Enrolment Years Publication Year Patients, n Prevalence of AF in TT, % DES, % TT at discharge, % Outcome comparisons, n Follow up, months
Orford JL et al.[9] R/SC 2000-2002 2004 66 39 0 100 None 1
Mattichak SJ et al.[10] R/SC 2001 2005 40 43 0 100 Against contemporary patients on DAPT, 42 12
Khurram Z et al.[11] R/SC NR 2006 107 70 75 100 Against contemporary patients on DAPT, 107 7
Porter A et al.[12] R/SC 2000-2004 2006 180 37 0 100 None 15
Lip GYH & Karpha M[13] R/SC 2000-2005 2006 35 100 14 17 Within population 1
Karjalainen PP et al.[14] R/MC 2003-2004 2007 239 70 42 48 Within population and against contemporary patients on DAPT, 239 12
DeEugenio D et al.[15] R/SC 2000-2005 2007 97 60 30 100 Against contemporary patients on DAPT, 97 6
Rubboli A et al.[16] R/SC 2002-2004 2007 49 60 0 41 Within population 1
Nguyen MC et al.[17] P/MC^ 1999-2006 2007 580 40 16 79 Within population 6
Rogacka RCA et al.[18] R/SC 1999-2006 2008 127 59 56 100 None 21
Ruiz-Nodar JM et al.[19] R/SC 2001-2006 2008 213 100 40 50 Within population 20
M.-Fernandez S et al.[20] R/SC 2002-2006 2008 104 100 66 49 Within population 12
Sarafoff N et al.[21] P/SC 2002-2007 2008 515 78 100 59 Within population 24
Maegdefessel L et al.[22] R/SC 1999-2004 2008 159 100 NR 9 Within population 16
Rossini R et al.[23] P/MC 2005-2006 2008 102 67 47 100 Against contemporary patients on DAPT, 102 18
Valencia J et al.[24] P/SC 2004-2006 2008 70 68 60 64 Within population 12
Gao F et al.[25] P/SC 2005-2008 2010 622 100 100 23 Within population 12
Sambola A et al.[26] P/MC 2003-2006 2009 405 67 46 68 Within population 6
Gilard M et al.[27] P/MC 2005-2006 2009 359 48 30 35 Within population 12
Hälg C et al.[28] R/MC 2003-2004 2009 813 NR 65.9 5 Within population 36
Halbfass P et al.[29] R/MC 2002-2006 2009 117 100 47 45 Within population 28
Helft G et al.[30] P/MC 2006-2007 2009 50 62 14 100 None 1
Olson KL et al.[31] R/SC 2003-2006 2009 175 23 81 100 Against contemporary patients on DAPT, 339 12
Baber J et al.[32] R/SC 2003-2007 2009 454 53 100 100* None*  
Persson J et al.[33] P/MC^ 1997-2005 2010 1183 35 32 56 Within population 12
Uchidab Y et al.[34] R/SC 2004-2007 2010 575 5 100 9 Within population 15
Guasch E et al.[35] R/MC 2005-2006 2011 33 29 NR 100 Against same patients after stopping clopidogrel 922 pt/months
Jang SW et al.[36] R/MC 2005-2007 2011 362 100 91 20 Within population 615
  1. OAC= oral anticoagulation; PCI-S= percutaneous coronary intervention with stent implantation; AF= atrial fibrillation;
  2. DES= drug eluting stent; TT= triple therapy; R= retrospective study; P= prospective study; SC= single center; MC= multi center; DAPT= dual anti-platelet treatment; NR= not reported. ^ post-hoc * evaluation of conventional TT vs modified TT (see text).